KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Operating Expenses (2016 - 2025)

Medpace Holdings' Operating Expenses history spans 11 years, with the latest figure at $555.2 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 35.01% year-over-year to $555.2 million; the TTM value through Dec 2025 reached $2.0 billion, up 20.04%, while the annual FY2025 figure was $2.0 billion, 20.04% up from the prior year.
  • Operating Expenses reached $555.2 million in Q4 2025 per MEDP's latest filing, up from $518.1 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $555.2 million in Q4 2025 to a low of $212.4 million in Q1 2021.
  • Average Operating Expenses over 5 years is $366.6 million, with a median of $394.7 million recorded in 2023.
  • Peak YoY movement for Operating Expenses: increased 0.03% in 2024, then surged 35.01% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $253.7 million in 2021, then rose by 25.22% to $317.7 million in 2022, then rose by 29.41% to $411.1 million in 2023, then increased by 0.03% to $411.2 million in 2024, then skyrocketed by 35.01% to $555.2 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Operating Expenses are $555.2 million (Q4 2025), $518.1 million (Q3 2025), and $477.0 million (Q2 2025).